Overview
- Elon Musk said implantation will shift to a streamlined, largely automated robotic procedure that inserts device threads through the dura without removing it.
- Neuralink reported 12 implanted participants actively using the system by September 2025, following initial human procedures that began in 2024.
- Early users, including the first patient, demonstrated cursor control, gaming, web browsing, and social posting using thought alone.
- The company raised $650 million in a 2025 Series E round at about a $9 billion valuation to fund manufacturing and clinical expansion.
- After an FDA rejection in 2022 and subsequent clearance to start trials, broader rollout remains contingent on further validation and regulatory approvals.